Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population (Q30977332)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population |
scientific article |
Statements
1 reference
Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population (English)
1 reference
1 reference
Yumi Asukai
1 reference
Amparo Valladares
1 reference
Eifiona Wood
1 reference
Kaisa Taipale
1 reference
Jorge Arellano
1 reference
Alejo Cassinello
1 reference
José Antonio Sacristán
1 reference
Tatiana Dilla
1 reference
29 January 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference